<?xml version="1.0" encoding="UTF-8"?>
<p>Our research group has extensive experience in the use of melatonin in the context of cardiovascular physiology. Melatonin can be administered at a total dose of at least 120 to 1,000 Î¼g/kg/subject weight and intravenously with a high safety profile (
 <xref rid="B36" ref-type="bibr">36</xref>, 
 <xref rid="B37" ref-type="bibr">37</xref>). An aggressive approach is required to prevent coronavirus disease progression and mechanical ventilation. Nordlund and Lerner (
 <xref rid="B49" ref-type="bibr">49</xref>) published a report years ago in which he gave humans one gram of melatonin daily for a month with no untoward effect. Melatonin has a large safety margin without serious adverse effects.
</p>
